Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Rebecca Wilkes's Articles

Renovos: Biotech start-up receives investment from research charity's fund

Medical research charity Orthopaedic Research UK (ORUK) has announced that biotech start-up, Renovos, will receive the first investment from its newly launched the Ronald Furlong Fund, a partnership between ORUK and HS., established this year in memory of the charity’s founder. 

Isansys: Australian hospital leads the world with patient monitoring trial

An Australian hospital has become the first in the world to use wireless monitoring technology hospital-wide, revolutionising its approach to the most basic process in healthcare – taking and recording patients’ vital signs.

TBAT: Innovate UK fund cutting-edge projects via their Smart Grant Competitions

Innovate UK fund cutting-edge projects via their Smart Grant Competitions. With multiple deadlines a year, these competitions give businesses from all industry sectors the opportunity to submit their innovative project ideas, to be awarded up to £2 million in Grant Funding.

The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year 

The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year . Apply now to join previous winners such as 2019’s Oxford Biomedica  

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

VivoPlex expands to Oxford medtech & digital health cluster

VivoPlex Group Ltd, which is transforming fertility treatment with precision medicine, has expanded to take on laboratory and office premises on Milton Park, Oxford.

Grey Wolf completes £2.5 million Series A2 financing for development of therapies targeting ERAP2

Oxford, UK – 9th January 2020 – Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), today announces it has completed a £2.5 million ($3.3 million) Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.

Absolute Antibody Launches VivopureX™ Recombinant Antibodies for In Vivo Research

Redcar, UK, January 7, 2020. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models.

Efficient Isolation of Circulating Cell Free DNA

AMSBIO has expanded its range of cfPure™ Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA).  A new cfPure™Max kit is now available for use on samples of 5mLs volume or greater.

Understanding the 3D shape of Oligodendrocytes

AMSBIO reports on the pioneering research published** by scientists at Stanford University Medical School that has cited Mimetix® aligned 3D cell culture scaffold supplied by the company to understand the architecture of the myelin sheaths which insulate neuronal axons, so they can transmit electrical impulses quickly and efficiently.
 

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.